Ken Griffin

Ken Griffin Citadel Advisors

AUM $125B
1-Year Est. Return 4.72%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Quarter Est. Return
1 Year Est. Return
+4.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$125B
AUM Growth
+$9.45B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
7,561
New
Increased
Reduced
Closed

Top Buys

1 +$1.43B
2 +$1.04B
3 +$1.03B
4
AAPL icon
Apple
AAPL
+$651M
5
NSC icon
Norfolk Southern
NSC
+$590M

Top Sells

1 +$1.24B
2 +$721M
3 +$706M
4
EW icon
Edwards Lifesciences
EW
+$661M
5
TXN icon
Texas Instruments
TXN
+$637M

Sector Composition

1 Technology 20.06%
2 Healthcare 14.01%
3 Financials 12.45%
4 Consumer Discretionary 10.85%
5 Industrials 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLTH icon
5301
Duluth Holdings
DLTH
$81.2M
$131K ﹤0.01%
+33,389
BCX icon
5302
BlackRock Resources & Commodities Strategy Trust
BCX
$826M
$130K ﹤0.01%
+12,827
GLBS icon
5303
Globus Maritime Ltd
GLBS
$35M
$130K ﹤0.01%
121,747
-62,443
EGAN icon
5304
eGain
EGAN
$286M
$130K ﹤0.01%
+14,939
CPIX icon
5305
Cumberland Pharmaceuticals
CPIX
$66M
$129K ﹤0.01%
41,445
-32,961
LYRA icon
5306
Lyra Therapeutics
LYRA
$6.39M
$128K ﹤0.01%
+19,484
GCV
5307
Gabelli Convertible and Income Securities Fund
GCV
$82.3M
$127K ﹤0.01%
30,828
+9,506
BCIC
5308
BCP Investment Corp
BCIC
$157M
$127K ﹤0.01%
11,004
-38,807
NUTR
5309
Nusatrip Inc
NUTR
$126K ﹤0.01%
+15,803
ALTI icon
5310
AlTi Global
ALTI
$500M
$126K ﹤0.01%
+35,394
IRIX icon
5311
IRIDEX
IRIX
$17.2M
$126K ﹤0.01%
109,473
+78,302
NXN icon
5312
Nuveen New York Tax-Free Income Portfolio
NXN
$47.6M
$125K ﹤0.01%
10,435
-370
DMAAU
5313
Drugs Made In America Acquisition Corp Units
DMAAU
$125K ﹤0.01%
11,964
-2,062
MB
5314
MasterBeef Group
MB
$104M
$125K ﹤0.01%
14,612
+3,104
KPRX icon
5315
Kiora Pharmaceuticals
KPRX
$7.94M
$125K ﹤0.01%
+44,573
FF icon
5316
Future Fuel
FF
$149M
$125K ﹤0.01%
+32,109
PPSI icon
5317
Pioneer Power Solutions
PPSI
$41.6M
$124K ﹤0.01%
28,779
-58,201
ASG
5318
Liberty All-Star Growth Fund
ASG
$329M
$124K ﹤0.01%
+22,289
DPRO
5319
Draganfly
DPRO
$193M
$123K ﹤0.01%
+15,127
LPBBU
5320
Launch Two Acquisition Corp Unit
LPBBU
$212M
$123K ﹤0.01%
11,647
ZKH icon
5321
ZKH Group
ZKH
$523M
$123K ﹤0.01%
43,048
-1,092
PZG icon
5322
Paramount Gold Nevada
PZG
$93.2M
$123K ﹤0.01%
99,692
-165,401
IMMR icon
5323
Immersion
IMMR
$212M
$122K ﹤0.01%
16,672
-102,998
EQ icon
5324
Equillium
EQ
$70M
$122K ﹤0.01%
85,557
-45,148
DTIL icon
5325
Precision BioSciences
DTIL
$108M
$122K ﹤0.01%
+22,142